Cell Meter™ 2-NBDG Glucose Uptake Assay Kit
Glucose metabolism, a process which converts glucose into energy, is a primary source of energy supply in most organisms. 2-NBDG [2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose], a fluorescently tagged glucose tracer, has been proven to effectively monitor glucose transportation in cells, as 2-NBDG transports into cells by the same glucose transporters (GLUTs) as glucose. Once 2-NBDG is uptaken in cells, it undergoes phosphorylation at C-6 position to give 2-NBDG-6-phosphate, which is well retained within the cells. Compared to other glucose tracers, such as 2-DG or FDG, 2-NBDG allows in situ measurements of 2-NBDG with high temporal and spatial resolution at single cell level. AAT Bioquest's Cell Meter™ 2-NBDG Glucose Uptake Assay Kit provides a sensitive and non-radioactive assay for measuring glucose uptake in cultured cells. In this kit, Assay Buffer I is used to enhance the uptake and retention of 2-NBDG in cells, while Assay Buffer II can improve the signal-to-background ratio of 2-NBDG in the cells. The fluorescence signal can be monitored by fluorescence microscope or flow cytometer with a 488 nm laser and 530/30 nm emission filter (FITC channel). Cell Meter™ 2-NBDG Glucose Uptake Assay Kit is the most robust tool for monitoring glucose transporters.
Example protocol
AT A GLANCE
Protocol summary
- Prepare cells with your test compounds
- Add 2-NBDG staining solution
- Incubate cells at 37oC for 20 minutes
- Remove 2-NBDG staining solution
- Wash cells with Assay Buffer I
- Analyze cells using fluorescence microscope or flow cytometer with 530/30 nm filter (FITC channel)
Important notes
Thaw all the components at room temperature before starting the experiment.
PREPARATION OF WORKING SOLUTION
Add 5 µL of 2-NBDG (10 mg/mL) (Component A) to 1.5 mL of Assay Buffer I (Component B) and mix well to make 2-NBDG staining solution. Protect from light. Note: This 2-NBDG staining solution is stable for 1 hour at room temperature. As the optimal staining conditions may vary depending on different cell types, it’s recommended to determine the optimal concentration of Component A for each specific experiment.
For guidelines on cell sample preparation, please visit
https://www.aatbio.com/resources/guides/cell-sample-preparation.html
SAMPLE EXPERIMENTAL PROTOCOL
- Add test compounds into the cells and incubate for a desired period of time (such as 24, 48 or 96 hours) in a 37°C, 5% CO2 incubator. For blank wells (medium without the cells), add the same amount of compound buffer. Note: Each cell line should be evaluated on an individual basis to determine the optimal cell density and incubation time. We incubated CHO-K1 cells with 20 mM Glucose for glucose competition assay, and 100 µM Phloretin for GLUTs inhibition assay. See Data Analysis for details.
- At the end of the treatment, centrifuge the plate for 5 minutes at 800 rpm with brake off prior to your experiment.
- Aspirate the supernatant without disturbing cells.
- Add 100 µL/well (96-well plate) or 25 µL/well (384-well plate) of 2-NBDG staining solution. Note: Optimal incubation time will need to be determined for each cell line and for each specific experiment. We incubated CHO-K1 cells at 37oC with 100 µM 2-NBDG (~34 µg/mL) for 20 minutes to show sufficient glucose uptake. See Data Analysis for details.
- At the end of the incubation, centrifuge the plate for 5 minutes at 800 rpm.
- Remove 2-NBDG staining solution without disturbing cells.
- For fluorescence microscope: Wash cells with Assay Buffer I (Component B) once. Keep cells in 100 µL/well (96-well plate) or 25 µL/well (384-well plate) of Assay Buffer II (Component C). Monitor the fluorescence signal using a fluorescence microscope with FITC filter.
- For flow cytometer: Detach cells if required using EDTA and resuspend cells in 100 µL/sample of Assay Buffer I (Component B). Monitor the fluorescence signal using a flow cytometer with 530/30 nm filter (FITC channel).
Spectrum
Citations
View all 7 citations: Citation Explorer
Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages
Authors: Sun, Ying and Yang, Huitong and Mei, Xue and Xia, Jinchan and Feng, Long and Gao, Jianfeng and Jiang, Wei and Jiang, Min and Hao, Xu and Feng, Yilin and others,
Journal: Drug Design, Development and Therapy (2025): 6647--6664
Authors: Sun, Ying and Yang, Huitong and Mei, Xue and Xia, Jinchan and Feng, Long and Gao, Jianfeng and Jiang, Wei and Jiang, Min and Hao, Xu and Feng, Yilin and others,
Journal: Drug Design, Development and Therapy (2025): 6647--6664
Enhancing $\beta$-Cell Function and Identity in type 2 diabetes: The Protective Role of Coptis deltoidea CY Cheng et Hsiao via Glucose Metabolism Modulation and AMPK Signaling Activation
Authors: Zhang, Shan and Zhang, Yueying and Wen, Zhige and Chen, Yupeng and Bu, Tianjie and Yan, Yanan and Ni, Qing
Journal: Phytomedicine (2024): 155396
Authors: Zhang, Shan and Zhang, Yueying and Wen, Zhige and Chen, Yupeng and Bu, Tianjie and Yan, Yanan and Ni, Qing
Journal: Phytomedicine (2024): 155396
SDHB reduction promotes oral lichen planus by impairing mitochondrial respiratory function
Authors: Zhang, Hui and Xu, Beiyun and Liu, Jin and Guo, Bin and Sun, Hongying and Yang, Qiaozhen
Journal: (2022)
Authors: Zhang, Hui and Xu, Beiyun and Liu, Jin and Guo, Bin and Sun, Hongying and Yang, Qiaozhen
Journal: (2022)
Young and undamaged recombinant albumin alleviates T2DM by improving hepatic glycolysis through EGFR and protecting islet $\beta$ cells in mice
Authors: Liu, Hongyi and Ju, Anji and Dong, Xuan and Luo, Zongrui and Tang, Jiaze and Ma, Boyuan and Fu, Yan and Luo, Yongzhang
Journal: (2022)
Authors: Liu, Hongyi and Ju, Anji and Dong, Xuan and Luo, Zongrui and Tang, Jiaze and Ma, Boyuan and Fu, Yan and Luo, Yongzhang
Journal: (2022)
IKCa channels control breast cancer metabolism including AMPK-driven autophagy
Authors: Gross, Dominic and Bischof, Helmut and Maier, Selina and Sporbeck, Katharina and Birkenfeld, Andreas L and Malli, Roland and Ruth, Peter and Proikas-Cezanne, Tassula and Lukowski, Robert
Journal: Cell death \& disease (2022): 1--14
Authors: Gross, Dominic and Bischof, Helmut and Maier, Selina and Sporbeck, Katharina and Birkenfeld, Andreas L and Malli, Roland and Ruth, Peter and Proikas-Cezanne, Tassula and Lukowski, Robert
Journal: Cell death \& disease (2022): 1--14
References
View all 14 references: Citation Explorer
Transport of a Fluorescent Analogue of Glucose (2-NBDG) versus Radiolabeled Sugars by Rumen Bacteria and Escherichia coli
Authors: Tao J, Diaz RK, Teixeira CR, Hackmann TJ.
Journal: Biochemistry (2016): 2578
Authors: Tao J, Diaz RK, Teixeira CR, Hackmann TJ.
Journal: Biochemistry (2016): 2578
2-NBDG as a marker for detecting glucose uptake in reactive astrocytes exposed to oxygen-glucose deprivation in vitro
Authors: Chen Y, Zhang J, Zhang XY.
Journal: J Mol Neurosci (2015): 126
Authors: Chen Y, Zhang J, Zhang XY.
Journal: J Mol Neurosci (2015): 126
Syzygium aqueum leaf extract and its bioactive compounds enhances pre-adipocyte differentiation and 2-NBDG uptake in 3T3-L1 cells
Authors: Manaharan T, Ming CH, Palanisamy UD.
Journal: Food Chem (2013): 354
Authors: Manaharan T, Ming CH, Palanisamy UD.
Journal: Food Chem (2013): 354
2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancer
Authors: Cai H, Peng F.
Journal: J Fluoresc (2013): 213
Authors: Cai H, Peng F.
Journal: J Fluoresc (2013): 213
In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog
Authors: Tsytsarev V, Maslov KI, Yao J, Parameswar AR, Demchenko AV, Wang LV.
Journal: J Neurosci Methods (2012): 136
Authors: Tsytsarev V, Maslov KI, Yao J, Parameswar AR, Demchenko AV, Wang LV.
Journal: J Neurosci Methods (2012): 136
Page updated on August 15, 2025